MedPath

Using Bluetooth Home Blood Pressure Monitors With Pharmacist Interventions

Not Applicable
Completed
Conditions
Hypertension
Interventions
Behavioral: Telehealth Follow-up Visits
Behavioral: Surveys
Device: Devices
Registration Number
NCT05606783
Lead Sponsor
University of South Florida
Brief Summary

Family Medicine patients with uncontrolled hypertension will be given a Bluetooth enabled home blood pressure machine to monitor their blood pressure every day for 6 weeks. The blood pressure results will be sent automatically to the patient's electronic medical record via applications on their iPhone. Study pharmacists will follow-up with the patients once per week via a telehealth appointment using the app VSee, where the blood pressure results will be reviewed. The pharmacists will also counsel the patients on lifestyle modifications in order to improve blood pressure.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
9
Inclusion Criteria
  • must be at least 18 years old
  • have a smartphone compatible with the mobile intervention (iPhone)
  • have been previously diagnosed with hypertension
  • have uncontrolled hypertension (SBP > 130 mmHg and/or DBP > 80 mmHg)
  • be under the care of a primary care physician in the Family Medicine Department of the USF Morsani Center for Advanced Care
  • have had at least one prescription filled at Pharmacy Plus within the last six months
  • speaks English fluently
Exclusion Criteria
  • already under the care of a clinical pharmacist in the Family Medicine department
  • pregnant
  • have a serious existing medical condition(s) that may affect their ability to self-monitor their blood pressure (for example, stroke, dementia)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Home blood pressure monitoringTelehealth Follow-up Visits* Smart Phones with Apple Health Software will be used to monitor blood pressure once a day, and results will be sent automatically to the patients EHR (Epic) * The Omron 10 Series Wireless Upper Arm Blood Pressure Device will be given to the patient to monitor blood pressure at home daily * Patients will be scheduled for a one-hour in-person appointment for the initial study visit where informed consent will be obtained, and for the final study visit
Home blood pressure monitoringSurveys* Smart Phones with Apple Health Software will be used to monitor blood pressure once a day, and results will be sent automatically to the patients EHR (Epic) * The Omron 10 Series Wireless Upper Arm Blood Pressure Device will be given to the patient to monitor blood pressure at home daily * Patients will be scheduled for a one-hour in-person appointment for the initial study visit where informed consent will be obtained, and for the final study visit
Home blood pressure monitoringDevices* Smart Phones with Apple Health Software will be used to monitor blood pressure once a day, and results will be sent automatically to the patients EHR (Epic) * The Omron 10 Series Wireless Upper Arm Blood Pressure Device will be given to the patient to monitor blood pressure at home daily * Patients will be scheduled for a one-hour in-person appointment for the initial study visit where informed consent will be obtained, and for the final study visit
Primary Outcome Measures
NameTimeMethod
Comfort8 weeks

Patient comfort in using home telemonitoring for blood pressure combined with pharmacist counseling and monitoring will be measured using a survey instrument with a Likert scale (4-point scale). (Most of the time; Some of the time; Seldom; Never) (Strongly agree; Agree; Disagree; Strongly disagree) (Nothing; Very little; Some; Knowledgeable)

Secondary Outcome Measures
NameTimeMethod
Determine if pharmacists' interventions improved BP8 weeks

BP readings were reported and evaluated to discover if these were improved with pharmacists' interventions.

Trial Locations

Locations (1)

USF Pharmacy Plus

🇺🇸

Tampa, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath